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ART ICLE Open Ac ce s s
Prenatal immune activation alters the adult
neural epigenome but can be partly
stabilised by a n-3 polyunsaturated fatty
acid diet
Paul Basil1,2, Qi Li1,3, Hongsheng Gui1, Tomy C. K. Hui1, Vicki H. M. Ling1, Chloe C. Y. Wong4, Jonathan Mill4,5,
Grainne M. McAlonan1,6 and Pak-Chung Sham1,3,7
Abstract
An unstable epigenome is implicated in the pathophysiology of neurodevelopmental disorders such as schizophrenia
and autism. This is important because the epigenome is potentially modiﬁable. We have previously reported that adult
offspring exposed to maternal immune activation (MIA) prenatally have signiﬁcant global DNA hypomethylation in the
hypothalamus. However, what genes had altered methylation state, their functional effects on gene expression and
whether these changes can be moderated, have not been addressed. In this study, we used next-generation
sequencing (NGS) for methylome proﬁling in a MIA rodent model of neurodevelopmental disorders. We assessed
whether differentially methylated regions (DMRs) affected the chromatin state by mapping known DNase I
hypersensitivity sites (DHSs), and selected overlapping genes to conﬁrm a functional effect of MIA on gene expression
using qPCR. Finally, we tested whether methylation differences elicited by MIA could be limited by post-natal dietary
(omega) n-3 polyunsaturated fatty acid (PUFA) supplementation. These experiments were conducted using
hypothalamic brain tissue from 12-week-old offspring of mice injected with viral analogue PolyI:C on gestation day 9
of pregnancy or saline on gestation day 9. Half of the animals from each group were fed a diet enriched with n-3 PUFA
from weaning (MIA group, n= 12 units, n= 39 mice; Control group, n= 12 units, n= 38 mice). The results conﬁrmed
our previous ﬁnding that adult offspring exposed to MIA prenatally had signiﬁcant global DNA hypomethylation.
Furthermore, genes linked to synaptic plasticity were over-represented among differentially methylated genes
following MIA. More than 80% of MIA-induced hypomethylated sites, including those affecting chromatin state and
MECP2 binding, were stabilised by the n-3 PUFA intervention. MIA resulted in increased expression of two of the ‘top
ﬁve’ genes identiﬁed from an integrated analysis of DMRs, DHSs and MECP2 binding sites, namely Abat (t= 2.46, p <
0.02) and Gnas9 (t= 2.96, p < 0.01), although these changes were not stabilised by dietary intervention. Thus, prenatal
MIA exposure impacts upon the epigenomic regulation of gene pathways linked to neurodevelopmental conditions;
and many of the changes can be attenuated by a low-cost dietary intervention.
Introduction
The epigenome exerts a modiﬁable control of gene
expression through covalent modiﬁcations such as cyto-
sine methylation or chromatin structural changes, which
are independent of the inherent DNA sequence1. The
epigenome is labile in nature2 and is thought to mediate
interactions between the genome and the environment. A
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diverse range of environmental exposures have been
associated with epigenetic modiﬁcations3–6; and an
unstable epigenome has been linked to complex neuro-
developmental disorders, including schizophrenia7 and
autism spectrum disorders (ASD)8.
Epidemiological and clinical studies indicate that pre-
natal exposure to maternal immune activation (MIA) is a
risk factor for the subsequent development of schizo-
phrenia9,10, ASD11,12 and bipolar disorder13. In rodents,
this can be modelled using the viral analogue, PolyIC, to
elicit an increase in inﬂammatory cytokine levels, espe-
cially interleukin 6 (IL6) during pregnancy14,15. The
rodent offspring exposed to this prenatal inﬂammatory
challenge show a robust brain and behavioural phenotype,
which mirrors features of neurodevelopmental dis-
orders16–22. Therefore, the consensus is that the MIA
model may give a helpful insight into the mechanisms
contributing to neurodevelopmental disorders in
humans23,24. However, although postnatal inﬂammatory
processes, and IL6 in particular, have been shown to alter
the epigenome25 and regulate the methyltransferase gene
expression26, little is known about the effects of a prenatal
immune activation on the postnatal hypothalamic
epigenome.
We previously reported the ﬁrst direct experimental
evidence that MIA causes global DNA hypomethylation
in the hypothalamus of offspring mice27. This brain region
is strongly implicated in the neurobiological symptoms of
schizophrenia28 and autism29. In particular, there is
increasing evidence that the hypothalamus is involved in
the onset of ‘prodromal’ manifestations, or precursors of
psychotic symptoms and structural and functional chan-
ges occur in this region during adolescence and young
adulthood30,31. However, while this study was an impor-
tant ﬁrst step, we did not have access to the technology to
identify MIA-induced methylation differences at the level
of individual genes and gene pathways. Nor did we
attempt to limit this epigenetic insult. For example, n-3
polyunsaturated fatty acid (PUFA) may have anti-
inﬂammatory effects32 and a n-3 PUFA-enriched diet in
individuals at ultra-high risk of developing psychiatric
disorders has been reported to lead to functional
improvement33. We reasoned that this relatively low risk
intervention may be useful to examine in the MIA model.
Therefore, in this study, we used the more compre-
hensive approach of reduced representation bisulﬁte
sequencing (RRBS) to quantify methylation differences at
CpG dense regions of the genome34, with single base
resolution to identify methylation differences in multiple
genes. We ﬁrst aimed to replicate our previous ﬁnding of
global DNA hypomethylation following prenatal MIA in
the mouse. We then tested the hypothesis that MIA-
induced enhancer and promoter methylation is correlated
with DNA hypersensitivity35, selective recruitment of
methyl-CpG-binding protein (MECP2) at CpG dinucleo-
tides36 and altered expression of downstream genes37. We
identiﬁed biologically relevant differentially methylated
regions (DMRs) and downstream target genes in an
integrated analysis of DMRs, DNase I hypersensitivity
sites (DHSs) and MECP2 binding sites using matching
publicly available Gene Expression Omnibus (GEO)
datasets. Regulation of gene expression by these epige-
netic marks was tested by mRNA quantiﬁcation of six
transcripts from selected ﬁve ‘top-hit’ genes. Finally, we
examined whether a diet enriched with n-3 PUFA intro-
duced immediately post weaning would stabilise the MIA-
affected epigenome and limit its modiﬁcation.
Materials and methods
Sample size and experimental design
Female and male C57BL/6N mice were bred and mated
in the Laboratory Animal Unit, The University of Hong
Kong. Mice were held in a 12 h light–dark cycle (lights off
at 1900 h), temperature and humidity-controlled (21 ± 1 °
C, 55 ± 5%) animal vivarium. Animals were maintained
under ad libitum food and water. All animal procedures
were approved by the Committee on the Use of Live
Animals in Teaching and Research at The University of
Hong Kong (CULATR 2640-12) and every effort was
made to minimise the number of animals used and their
suffering.
Preliminary evaluations based on our pilot study27
suggested that ~10 individual samples give a power of 80%
at an alpha= 0.05 for detecting a Δmethylation of at least
7% between the groups. The sample size in this study was
calculated according to ‘experimental units’. This is con-
sidered to be an efﬁcient and economical way to reduce
variance, as all the animals exposed to the same treatment
and shared the same conditions are treated as a single
unit38,39. In this case, an experimental unit comprised
same-sex litter-mates; exposed to MIA or control saline in
prenatal life; fed the same diet; and housed in the same
cage. In brief, of N= 11 pregnant mice initially used, six
were exposed to PolyI:C (5 mg/kg, injection via the tail
vein22), ﬁve to saline vehicle, on gestation day 9. We used
day 9 because it is close to key developmental stages such
as neural tube closure and has been reported by our group
and others to reliably disrupt brain and behaviour10,22.
This resulted in a total of N= 39 individual offspring
exposed to MIA and N= 38 exposed to saline. After
weaning, the same sex offspring from one litter were
housed together in one experimental unit. This approach
has been recommended to reduce variability within a unit
to ensure any differences between conditions will be
meaningful; this also increases the statistical power to
detect differences39. Each experimental unit comprised
2–6 animals. As one of the saline-exposed mothers had
delivered a large number of offspring, these were split into
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two units of each sex for future housing and analysis. This
provided a total of 12 MIA-exposed experimental units
(six male units: six female units) and 12 experimental
units exposed to saline (six male units: six female units).
Half the male units (three) and half the female units
(three) in the MIA and saline groups were given standard
diet (n-6-PUFA) and the other half were given n-3-PUFA-
enriched diet. Please see Table 1 and Supplementary
Figure 1 for further details.
Offspring were weaned and sexed on postnatal day 21,
then randomly allocated to a diet enriched with n-3 PUFA
or a standard laboratory control diet (isocaloriﬁc and with
the same total fat content, but a greater proportion of n-6
PUFA). The diets were custom prepared and supplied by
Harlan (Harlan Laboratories UK Ltd.). The control diet,
based on the standard AIN-93G rodent laboratory diet40,
contained 65 g/kg corn oil and 5 g/kg ﬁsh oil with an
approximate (n6):(n3) ratio of 13:1. The n-3 PUFA diet
contained 35 g/kg corn oil and 35 g/kg menhaden ﬁsh oil
with an approximate (n6):(n3) ratio of 1:1 (please see
details in Supplementary Table 1). Thus, there were four
groups (n-6 SAL; n-6 POL; n-3 SAL; n-3 POL) with six
experimental units/group (including three males and
three females). The units remained ‘naïve’—free from any
subsequent interference until each animal was sacriﬁced
by cervical dislocation at 12-weeks. The hypothalamus
was rapidly dissected and frozen in liquid nitrogen until
further use. DNA was isolated from brain tissue using the
Qiagen EZ1 DNA kit, and equal amount of DNA each
sample in the unit was combined and an equal amount of
DNA was taken from each unit for analysis after quality
checks and normalisation. Sample identity was concealed
and uniquely coded vials were randomised at data gen-
eration and analysis stages.
Genome-wide analysis of DNA methylation
To allow comprehensive, unbiased proﬁling of DNA
methylation, the RRBS method was followed to capture
target regions for library preparation41. 2.5 µg of genomic
DNA was digested overnight with MspI enzyme (New
England Biolabs, Ipswich, MA), using 20 units of enzyme
per µg of DNA to ensure complete digestion. The size-
selected targeted fragments were bisulﬁte converted using
EZ DNA methylation kit (Zymo Research, Irvine, CA) and
checked on a 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA) and Qubit 2.0 Fluorometer (Life Tech-
nologies, Grand Island, NY). A double-stranded DNA
library was produced using Illumina TruSeq DNA library
preparation system (Illumina, San Diego, CA). These
libraries were PCR ampliﬁed, normalised and qPCR was
performed to conﬁrm quality, and were then pooled by
ﬂuorometric quantitation readings in equimolar con-
centrations for two lanes of a Hiseq 2000 sequencer ﬂow
cell. We performed single-end sequencing with 51 bp read
length. Read quality was examined by FastQC, using
Phred score of 20 as a cutoff (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). All samples were
screened and deemed of high quality for inclusion in
subsequent analysis.
RRBS data processing
We aligned 16–20 million, adapter-trimmed (minimum
overlap length set to 12, the minimum read length to keep
after adapter removal set to 22 and allowed two mis-
matches), 50 nucleotides, reduced-representation bisul-
phite sequences from 24 experimental units. Read depths
were normalised using quantile normalisation between
experimental units to avoid bias introduced by systematic
differences in the amount of sequences from experimental
units. The quantitative methylation score at each inter-
rogated CpG site was calculated as the ratio of the
number of cytosines to the sum of the number of cyto-
sines and thymine detected at that site. This gave a per-
centage of DNA methylation for each CpG site, ranging
from 0 (unmethylated) to 100 (fully methylated).
Identiﬁcation of MIA and diet-associated differentially
methylated regions (DMRs)
DMRs were identiﬁed in three planned comparisons.
This was to address the following questions:
(i) Does MIA affect the methylome? This was
addressed by comparing the MIA and saline
exposure in groups given the ‘standard’ control diet
(n-6-SAL vs n-6-POL).
(ii) Does dietary intervention with n-3 PUFA limit
MIA-induced changes to the methylome? This was
addressed by comparing the MIA group given n-3
PUFA diet and control diet (n-3-POL vs n-6-POL).
(iii) The third comparison was to address any non-
speciﬁc effects of the n3-PUFA diet in the saline
controls and therefore compared n-3-SAL and n-
6-SAL.
Gene or locus annotation and ranking
The DMRs identiﬁed were annotated to the nearest
genomic feature using the mouse reference gene list
(mm9, downloaded from the UCSC genome browser
Table 1 Experimental units and animal numbers
Saline PolyI:C
n-6 n-3 n-6 n-3
Units 6 6 6 6
Animals (male:female) 20 (9:11) 18 (10:8) 18 (10:8) 21 (8:13)
Saline group (n= 38) and polyI:C group (n= 39) with the number of
experimental units and animals in each group
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(http://genome.ucsc.edu/)). Approximately 13% of the
CpG sites typed in this study spanned promoters, ~14%
exons, ~21% introns and ~52% were intergenic. Similarly,
~20% of the CpG sites examined were located in CpG
islands and ~5% were in shore regions. We identiﬁed ~25
000 locations in the genome with variable number of CpG
sites covered. Supplementary Figure 2 shows the distances
from the typed locations to the nearest feature (gene,
promoter, or CpG island).
From the group comparison analysis, a number of
DMRs were identiﬁed. To detect and rank biologically
relevant DMRs, we considered both the statistical sig-
niﬁcance and magnitude of change of approximately 25
000 locations8.
(1)
A multiple testing false discovery rate (FDR)-based
Benjamini–Hochberg correction was applied followed by
ﬁltering at a ‘q-value’ cut off <0.0142.
(2)
The distance from the DMR to the nearest gene was
used for functional annotation.
(3)
The number of CpG sites covered within the same
genomic region (within 250 bp) was used to identify
DMRs.
(4)
Differentially methylated CpG sites with q-value < 0.01
were ranked according to the magnitude of change
(Δmethylation values).
Pathway and network analysis
DMRs with Δmethylation values more than 3% were
mapped to the nearest gene43. Pathway and network
analysis using the core analysis function from Ingenuity
Systems (http://www.ingenuity.com) was used to deter-
mine what pathways incorporated these genes44.
Global DNA methylation analysis
The global levels of DNA methylation at CCGG sites
were evaluated using ~12 million RRBS–NGS reads by an
in-house method. This method relies on the ﬁrst three
bases of reads beginning with CGG or TGG, which in
turn depends on the methylation status of the restriction
site (CCGG). Calculating the C/T ratio at this CpG site
generates a measure of global CCGG methylation45. In
effect, every read from a directional RRBS library,
regardless of alignment to reference, provided informa-
tion on at least one CpG at the start of the reads.
DNase I hypersensitivity and MECP2 binding
CpG sites were annotated to the proximal mm10
enhancers from the mouse Encode project46. This was to
identify biologically relevant sites and its affected target
genes. DHSs and MECP2 occupancy sites were analysed
by calculating tag density at the CpG sites using SeqMI-
NER47. Default parameters were used and DHS data was
ﬁltered with a cut off tag density >5 to improve signal-to-
noise ratio. Publicly available datasets of MNase sequen-
cing (GSE66869) and MECP2 ChIP sequencing
(GSE66868) were used in this analysis. These datasets
were selected based on the availability of high depth
DNase I hypersensitivity data and MECP2 chromatin
binding data from young adult mouse hypothalamus.
Effect of n-3 PUFA intervention on this list of DMRs was
also tested.
mRNA quantiﬁcation
Total RNA was isolated from three biological replicates
using TRIzol (Invitrogen) and cDNA was synthesised with
oligo dT primers (EvoScript cDNA synthesis kit; Roche).
Quantitative PCR was performed using 10 ng of cDNA
and LightCycler 480 SYBR Green I reagent in a Light-
Cycler 480 PCR apparatus (Roche). GABA transaminase
(Abat) and Gnas9 were chosen because they have differ-
ences in methylation in enhancer regions and Gnas6,
spindle assembly associated (Sﬁ1), ceramide kinase (Cerk)
and opioid receptor, kappa 1 (Oprk1) were chosen
because they were the most statistically signiﬁcant DNA
methylation changes. 18S rRNA was used as internal
control. mRNA speciﬁc primer sets used in the study are
listed in Supplementary Table 2. The relative standard
curve method was used to get the mRNA levels in each
sample and 18S rRNA was used to normalise amounts of
mRNA between samples. Statistical signiﬁcance of the
changes in expression levels were calculated in R project
using General Linear Model (GLM).
Statistical analysis
Statistical analyses of global DNA methylation and gene
expression data used a GLM to identify any main effect of
group, sex, or dietary intervention or any interaction
between these factors; unpaired two-tailed t-tests were
used to explore the data post-hoc. The criterion for sta-
tistical signiﬁcance was set as p < 0.05 and analyses were
conducted using R statistical package (http://www.r-
project.org/).
MethylKit (R platform) was used to perform a principal
component analysis, a cluster analysis and sample-to-
sample genome-wide region-speciﬁc analysis in the
planned comparisons. A logistic regression model was
ﬁtted per CpG and we tested if treatment vector has any
effect on methylation or not.
log
πi
1 πi
 
¼ β0 þ β1Treatmenti
The criterion for statistical signiﬁcance was set at
Benjamini–Hochberg (BH) q < 0.01. Ingenuity pathway
analysis was used to identify pathways, networks and
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diseases from the top-ranked gene list employing a Fish-
er’s exact test for gene enrichment. The top differentially
methylated sites were tested using a hypergeometrical test
for over-representation in the functional annotation tools,
DHS and MECP2 occupancy.
The same DMRs and genes identiﬁed as differentially
methylated in the MIA-exposed brain compared to the
control group were screened for any effect of n-3 PUFA
using paired Wilcoxon signed rank test with continuity
correction. Distribution of methylation status of these
genes was tested using a Kolmogorov–Smirnov test to
identify any skew in distribution.
Results
Quantitative DNA methylation was measured across ten
million CpG locations of the genome in every sample
from an estimated 486 254 fragments of genomic DNA.
Supplementary Figure 2 shows the distribution of per-
centage of methylation at all CpG locations. This example
ﬁgure reveals a typical distribution from 0 to 100%, as
expected from a heterogeneous sample containing a
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Fig. 1 DNA hypomethylation in hypothalamus of MIA-exposed
offspring. Percent methylation is shown on the y-axis; error bars are
standard error of the mean (SEM). *p < 0.05; **p < 0.005; p values
calculated from a stratiﬁed t-test between a maternal immune
activation and control groups given a control diet and b MIA groups
given a n-3 PUFA or control diet. Treatment groups shown on the x-
axis: n-3 POL—Omega3 PolyI:C, n-6 POL—Omega6 PolyI:C, n-3 SAL—
Omega3 Saline, and n-6 SAL—Omega6 Saline
D
A
N=165 genes
aﬀected by MIA and
stabilized by n-3 PUFA
Genes Altered 
by MIA
Genes Altered 
by Diet
40 24
B QQ Plot for MIA Induced DMRs
C QQ Plot for DMRs Following 
n-3 Intervenon
Fig. 2 Genome-wide methylation differences in the hypothalamus. a MIA-induced DMRs plotted against chromosome locations, with Track1:
mouse genome with cytobands. Track2: connectors between the gene names to the chromosome location. Track3: differentially methylated genes
connected to the locations. Track4: red dots indicating hypermethylated sites and blue dots indicating hypomethylation. Track5: CpG site distance to
the gene; red indicates after transcription start site (TSS) and blue indicates before TSS. Track6: negative log q-values for the corresponding CpG sites
at that genomic location. Track8: comparison of Δmethylation distribution detected from MIA effect and omega-3 effect. Y axis indicates percentage
Δmethylation values, x axis represents CpG sites from 165 stabilised genes. b Quantile–Quantile plot for MIA-induced differentially methylated CpG
sites, ‘observed’ p values are plotted on the y axis against ‘expected’ values on the x axis. The red line indicates the distribution of p value under the
null progression. Control group comparison is expected to follow the null and is plotted to check the level of ‘noise’. c Quantile–Quantile plot for
differentially methylated CpG sites following dietary intervention. Observed p values are plotted observed on y axis against expected values on x axis.
The red line indicates the distribution of p value under the null progression. Control group comparison is expected to follow the null and is plotted to
check the level of ‘noise’. d Methylation proﬁle of genes affected by MIA after n-3 intervention. (1) 165 genes stabilised by n-3 PUFA dietary
intervention (Orange); (2) 40 genes affected by MIA but not affected by n-3 PUFA (Blue) and (3) not altered by MIA but altered by n-3 PUFA diet
(Green)
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number of cell types. It also shows a peak at the 50%
mark, which usually represents imprinted genes with one
allele fully methylated and the other not methylated.
Global methylation at CCGG sites are associated with MIA
and n-3 PUFA intervention
Global DNA methylation in the MIA-exposed hypo-
thalamus was signiﬁcantly lower than in saline groups (F
(3, 20)= 7.67, β=−5.27, p= 3.49 × 10−04) and the overall
effect of n-3 PUFA dietary intervention was to increase
global DNA methylation (F (3, 20)= 7.67, β= 2.534, p=
0.05). There was no signiﬁcant effect of sex or any
interaction with sex; 46.53% of the variance in global DNA
methylation was explained by the regression model.
There was a signiﬁcant group × diet interaction (F (4,
19)= 9.96, β= 6.07, p= 0.009). This resulted from sig-
niﬁcant hypomethylation in hypothalamus of the n-6-
POL compared to the n-3-POL group and was conﬁrmed
using t-test (t= 3.16, p= 0.011, Δmethylation= 5.57),
especially in males (t= 4.55, p= 0.033, Δmethylation=
8.66). Means (SEM) are shown in Fig. 1.
Widespread methylation differences in DNA were
observed in hypothalamus
In total, 320 differentially methylated CpG sites were
identiﬁed as passing through q-value signiﬁcance of <0.01
in a comparison between n-6-SAL vs n-6-POL. These
included both hypomethylated and hypermethylated sites.
Figure 2 shows the distribution of signiﬁcance of differ-
entially methylated CpG sites in MIA-exposed tissue vs
saline control. The overall distribution of signiﬁcance of
DNA methylation differences showed a highly signiﬁcant
skew, with a number of CpG sites demonstrating an
epigenome-wide signiﬁcant difference in DNA methyla-
tion (Supplementary Table 3). A sex stratiﬁed analysis also
returned similar results.
A gene annotation was performed on the DMRs and
these CpG sites fell onto 204 genes, of which 36 genes
Table 2 Top sites showing MIA and n-3 induced differential methylation
n-6-SAL vs n-6-POL n-3-POL vs n-6-POL
Gene name Distance to the gene q-value Δmethylation % q-value Δmethylation % CpG sites
Sﬁ1 16 < 1.10 × 10−16 −26.7 to −6.59 7.18 × 10−14 −23.48 to −5.1 9
Sox17 −62863 < 1.10 × 10−16 10.54 to 18.23 2.58 × 10−13 9.58 to 16.02 6
Pex2 −284438 < 1.10 × 10−16 −17.17 to 14.54 2.60 × 10−11 −10.92 to 10.31 5
Oprk1 −237706 < 1.10 × 10−16 13.94 to 18.02 1.38 × 10−10 10.17 to 13.84 2
Cerk −9086 < 1.10 × 10−16 −30.08 to −26.79 < 1.10 × 10−16 −23.16 1
Erdr1 −1137.5 < 1.10 × 10−16 −30.08 to −26.79 4.11 × 10−13 −27.73 to −20.44 2
Eya1 196687 < 1.10 × 10−16 16.01 to 24.08 1.30 × 10−11 10.50 to 18.79 2
Filip1l 38241 < 1.10 × 10−16 7.87 3.07 × 10−13 6.6 1
G530011O06Rik −30472 < 1.10 × 10−16 −34.15 to −32.87 < 1.10 × 10−16 −31.52 to −24.74 2
Gm15386 −272508 < 1.10 × 10−16 9.02 to 13.29 1.36 × 10−13 8.86 to 11.66 2
Pi15 −134875 < 1.10 × 10−16 15.12 < 1.10 × 10−16 12.57 1
Rn45s 2643 < 1.10 × 10−16 −13.6 to 15.71 1.03 × 10−11 −10.53 to −7.62 3
B020004J07Rik −27301 1.44 × 10−13 −32.83 0.001 −19.01 1
3110070M22Rik −120 2.03 × 10−13 −9.74 to 9.93 1.03 × 10−9 −7.79 to 4.61 3
Zbtb24 −12896 1.49 × 10−11 −30.62 0.028 −14.75 1
Gm10377 82454 9.70 × 10−10 26.22 5.86 × 10−4 18.25 1
Gm5415 −472527 1.50 × 10−9 9.34 6.09 × 10−7 8.23 1
4930515L03Rik −71170 2.40 × 10−9 28.79 0.166 10.06 1
1700030C10Rik 582097 3.59 × 10−9 −11.27 0.001 −7.67 1
2900097C17Rik 29994 4.24 × 10−9 −28.16 0.003 −18.63 1
Itgbl1 11323 3.08 × 10−8 26.72 0.022 15.49 1
Plcd3 17139 6.12 × 10−8 −29.14 0.004 −21.17 1
Gm17026 54903 1.06 × 10−7 23.73 0.002 17.17 1
Rpia 703669 1.24 × 10−7 22.35 1.81 × 10−4 17.75 1
Mir684-1 −41569 1.56 × 10−7 −26.42 0.001 −20.93 1
9330188P03Rik 196 2.15 × 10−7 −24.76 0.152 −10.96 1
Zp3r 28668 4.36 × 10−7 27.79 0.025 18.48 1
Ppp1r15b 40280 7.88 × 10−7 −27.33 0.002 −19.61 1
List of top differentially methylated genes. n-6-SAL vs n-6-POL comparison lists the MIA effect, n-3-POL vs n-6-POL comparison lists the n-3 effect. Average distance
from the CpG sites to the nearest gene, q-value—BH corrected p-value, Δmethylation—difference in methylation in percentages listed as a range, number of
differentially methylated CpG sites are listed in the gene. The lowest q-value among the differentially methylated CpG sites is listed
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have been reported to be associated with schizophrenia
and four genes have been found to be associated with
autism. Supplementary Figure 3 shows the genomic
location of the top DMRs.
Among the genes mapped by DMRs, 164 genes were
identiﬁed as hypomethylated, 33 genes were hyper-
methylated and seven genes had both hypomethylated
and hypermethylated sites. Overall, a number of differ-
entially methylated CpG sites passed the signiﬁcance level
q-value < 1.0 × 10−16 (logistic regression). The list of top
differentially methylated CpG sites is given in Table 2.
Nine CpG sites located in the promoter region of the gene
encoding Sﬁ1 were hypomethylated in the MIA-affected
hypothalamus compared with control group (Δmethyla-
tion=−10.05 to 26.70%, p < 1.0 × 10−16). An enhancer
region upstream to the gene Abat was hypomethylated in
the MIA-affected hypothalamus compared with control
group (Δmethylation=−14.32%, p < 0.004). Similarly, the
promoter region of the Gnas transcript 9 was also hypo-
methylated in the MIA-affected hypothalamus compared
with control group (Δmethylation=−19.74%, p < 4.96 ×
10−4). Table 2 and Fig. 2 show the differentially methy-
lated genes in this comparison.
Pathways and networks relevant to neurodevelopment are
affected by MIA
The differentially methylated genes in n-6-SAL and n-6-
POL groups that survived multiple testing correction (q-
value < 0.01) were entered into an Ingenuity Pathway core
analysis (IPA) (listed in Supplementary Table 3). IPA
analysis revealed the top scoring functional networks
differentially affected by MIA exposure were ‘nervous
system development and function’, followed by ‘cellular
development’ and ‘embryonic development’. Please see
Supplementary Table 4.
Many MIA-associated DMRs were DHSs and MECP2 afﬁnity
sites
DHSs indicated the presence of highly expressed gene
promoters, enhancers and chromatin state at the differ-
entially methylated CpG sites. Please see Supplementary
Table 5. Among the annotated DMRs, 64 sites were DHSs
and MECP2 binding sites. In general, DMRs showed an
overrepresentation of DHSs (hypergeometric test, p <
0.03) and an overrepresentation of MECP2 binding sites
(hypergeometric test, p < 0.001). DHS or MECP2 afﬁnity
was not different at hypomethylated sites compared to
hypermethylated sites. Figure 3 shows the overlap
between number of DMRs, DHSs and MECP2 binding
sites.
MIA-associated differential methylation induced gene
expression
Six differentially methylated sites were at annotated
mouse enhancers (reference build mm10). As indicated by
the bioinformatic analyses, MIA exposure-induced
enhancer hypomethylation signiﬁcantly increased Abat
mRNA level in the MIA-affected group (GLM, F (3, 20)=
4.12, β= 3.96, p= 0.003). Please see Fig. 3. Although MIA
induced hypomethylation at Gnas6 and Gnas9 promoter
regions, only Gnas9 mRNA was signiﬁcantly increased in
the MIA-affected group (F (3, 20)= 3.92, β= 4.52, p=
0.003). Please see Fig. 3. Finally, there was a trend towards
expression changes following MIA exposure in the other
selected genes.
Dietary intervention stabilises the epigenome
In a comparison between n-3-POL and n-6-POL groups,
101 CpG sites were differentially methylated (logistic
regression, q-value < 0.01). These included hypomethy-
lated and hypermethylated sites. Supplementary Table 3
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Fig. 3 Effect of MIA-associated DMRs in gene transcription. a Overlap between the DMRs, DHSs and MECP2 binding sites. b Abat and Gnas9
mRNA quantiﬁcation using RT-qPCR. Quantities are calculated against a standard curve and values are normalised to 18S RNA. Error bars are standard
error of the mean (SEM). *p < 0.05; p values calculated from a stratiﬁed t-test between MIA and control groups given a control diet
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shows the DMRs identiﬁed in this comparison. Figure 2
shows the distribution of signiﬁcance of differentially
methylated CpG sites in n-3 PUFA vs control diet MIA
group comparison. A comparison between n-3-SAL and
n-6-SAL groups showed that the control group was not
affected by n-3 PUFA administration. A sex stratiﬁed
analysis also returned similar results. Differentially
methylated CpG sites were annotated to the nearest
gene. These signiﬁcant CpG sites fell onto 64 genes of
which 15 have been reported to be associated with
schizophrenia and one gene (Gnas) was a complex
imprinted locus.
Among the 64 differentially methylated genes identiﬁed,
34 were hypomethylated, 29 genes were hypermethylated
and one gene had both hypo and hyper-methylated sites.
The top differentially methylated sites identiﬁed were
located in the promoter region of the gene encoding Sﬁ1.
Eight CpG sites in this gene promoter were hypomethy-
lated in hypothalamus of the control diet group compared
with the n-3 PUFA supplemented group (Δmethylation=
−8.51 to 23.48%, p < 1.0 × 10−16). The list of top differ-
entially methylated CpG sites is given in Table 2. Figure 2
shows the number of differentially methylated genes in
this comparison.
A pathway core analysis was performed on the differ-
entially methylated genes in the n-3 PUFA MIA and
control diet MIA groups that passed through multiple
testing correction (q < 0.01); see Supplementary Table 3.
IPA analysis revealed the top scoring functional network
impacted by n-3 PUFA intervention was; ‘nervous system
development and function’, followed by ‘cellular devel-
opment’, ‘inﬂammatory disease’ and ‘psychological dis-
ease’. See Supplementary Table 4.
A number of MIA-associated DMRs were stabilised by n-3
PUFA intervention
80.88% of the genes altered by MIA (165/204) were
rescued by the dietary intervention. Δmethylation values
for the 165 genes (affected by MIA) from n-6-SAL vs n-6-
POL comparison was plotted against Δmethylation values
for the corresponding genes from the n-3-POL vs n-6-
POL comparison (affected by n-3 PUFA intervention).
These 165 genes were identiﬁed as differentially methy-
lated after MIA. In the MIA group with dietary inter-
vention, this differential methylation pattern was no
longer present. Thus, these genes had been stabilised by
dietary intervention. Please see Fig. 2. The difference
between the empirical distributions of both groups were
signiﬁcantly different (D= 0.40, Kolmogorov–Smirnov
test p= 2.2 × 10−16). Furthermore, the difference between
untreated comparison Δmethylation and treated com-
parison Δmethylation was signiﬁcant (V= 8090, p < 2.2 ×
10−16) in a paired Wilcoxon signed rank test. Pathways
and functions identiﬁed from 165 genes stabilised by n-3
PUFA intervention following MIA exposure is listed in
Supplementary Table 6.
Dietary n-3 PUFA intervention alters chromatin state at
MIA-associated DMRs
Among the DMRs identiﬁed as DHSs, hypomethylated
sites were stabilised by dietary n-3 PUFA (t= 2.28, p=
0.02) when compared to control DMRs. Hypermethylated
DHSs were not affected by dietary n-3 PUFA.
Dietary n-3 PUFA intervention did not alter expression of
selected target genes
There was no signiﬁcant effect of dietary intervention,
sex, any interaction with diet or sex; more than 38.23% of
the variance in gene expression was explained by the
regression models. Dietary n-3 PUFA intervention
appeared to limit expression differences in Sﬁ1, Cerk,
Gnas6 in both sexes; Gnas9 and Oprk1 expression dif-
ferences were limited by n-3 PUFA in females. However
these observations did not reach statistical signiﬁcance.
Please see Supplementary Figure 4.
Discussion
This study was a comprehensive analysis of DNA
methylation differences in the hypothalamus from a
mouse model relevant to autism and schizophrenia. It also
examined the effect of n-3 PUFA early dietary
intervention.
Global DNA methylation differences and response to n-3
PUFA in offspring exposed to MIA
We documented that a global hypomethylation of
CCGG locations in DNA extracted from the hypothala-
mus is associated with prenatal exposure to immune
activation. This is consistent with the global methylation
differences observed in our earlier study using a LINE1
measure27. The mechanism underlying this effect of MIA
is unclear and may be due to both the nature of the
challenge and the timing of exposure. For example, the
effects of MIA are mediated at least in part by IL-648 and
in other systems, speciﬁcally oral cancer, IL-6 has been
shown to cause global LINE-1 hypomethylation25. In
addition, however, other prenatal exposures such as val-
proic acid, which are linked to adverse neurodevelop-
mental outcomes, have been shown to modify the
epigenome including through DNA hypomethylation49.
The results reported here concur with evidence from
human studies and other animal studies that environ-
mental exposures have epigenetic effects50,51. For exam-
ple, changes in global CCGG methylation in human blood
samples are linked to adverse prenatal environment such
as maternal exposure to famine52; and are also observed in
the thalamus and hippocampus of mice exposed to mal-
nourishment53. Moreover, the picture of predominant
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hypomethylation with some hypermethylation at a num-
ber of DNA sites within hypothalamic tissue of adult
offspring of immune challenged mothers is broadly con-
sistent with a recent study of prefrontal changes following
MIA by Meyer group54.
We have now extended our previous ﬁndings and report
that hypomethylation due to MIA can be limited by early
dietary intervention by n-3 PUFA. These results ﬁt with a
number of studies that report beneﬁcial effects of n-3
PUFAs on the epigenome55, development56 and in clinical
treatment57.
DNA methylation differences affecting chromatin state and
gene expression
Extended analysis of the methylome, MNase-seq data
and MECP2 ChIP-seq data showed a pattern of extensive
DHS and MECP2 binding (Supplementary Figure 5) at
DMRs. Mapping DHSs is an established method of
identifying key transcriptional regulatory regions58. An
overrepresentation of DHSs in the DMRs indicated there
were MIA-associated differences in the transcriptional
programme. The overrepresentation of MECP2 recruit-
ment at these sites is also consistent with this.
We selected six ‘top-hits’ for mRNA analysis. First we
found overexpression of Abat in the MIA-exposed
hypothalamus. Abat is responsible for the catabolism of
gamma-aminobutyric acid (GABA) in brain, therefore this
observation ﬁts with the evidence that GABAergic sig-
nalling is disrupted in neurodevelopmental conditions
such as schizophrenia and ASD. For example, increased
GABA breakdown by ABAT might contribute to the
decreased GABA content reported in cerebrospinal ﬂuid
of ﬁrst-episode psychosis59. The second gene we exam-
ined was Gnas9. Gnas9 is a paternally expressed transcript
coding the α-subunit of G-protein coupled receptors
(GPCRs) such as GABAB receptors. Therefore, again
GABA pathways appear to be particularly targeted by
MIA. This susceptibility of GABA to MIA in prefrontal
cortex has previously been reported by the Meyer
group54,60,61 and we suggest changes in methylation state
are the possible antecedent. However, an alternative
explanation for overexpression of Gnas9 may be that it is
a secondary response to decrease in GABA elicited by
excess ABAT activity.
Finally, we observed a trend towards an increase in Sﬁ1,
Cerk, Gnas6 expression in MIA-exposed males and
Oprk1 expression in both sexes compared to the control
group; Sﬁ1, Gnas6, and Cerk expression was lower in
MIA-exposed females compared to the control group.
Thus, it appears that at least some of the effects of MIA
on gene expression are sex speciﬁc and the current
stratiﬁed analysis lacked statistical power to identify any
true effect.
Speciﬁc genes, gene pathways and response to n-3 PUFA
intervention
MIA-induced DNA methylation differences at indivi-
dual CpG sites were concentrated within genes for ‘ner-
vous system development and function’. Moreover, the
genes modiﬁed by prenatal MIA included many of those
already associated with schizophrenia and autism,
including Abat, Gnas, Cerk, Cnnm2, Pex5l, Ppp1r15b,
Slc19a2, Pi15 and Pex2. The pathways inﬂuenced by these
genes, such as the ceramide signalling pathway and
AMPK signalling pathway are those involved in cell sig-
nalling and synaptic transmission fundamental to neuro-
development and brain function62,63. The IL-6 signalling
pathway was also enriched in this analysis of the impact of
MIA. This latter observation is entirely consistent with
the key role of IL6 in the MIA mouse model15. For
example, the post-natal behavioural sequelae of prenatal
MIA can be prevented by IL6 gene knock-out, or anti-IL6
antibodies48.
n-3 PUFA dietary supplementation from weaning atte-
nuated the majority of MIA effects on the epigenome
including genes involved in ‘regulation of transcription’;
but excluding genes involved in ‘phosphoprotein phos-
phatase activity’. We did not examine the behavioural
consequences of this intervention in the present study.
This was based on increasing evidence that the post-natal
environment alters neuronal metabolism and structure
(e.g. Ding et al.64; Zhou et al.65) and causes epigenetic
changes66, which might have confounded interpretation.
However, we have previously shown that this same n-3
PUFA intervention prevented the pathological elevation
of N-acetyl aspartate in the brains of young adult animals
exposed to MIA in-utero; as well as the emergence of
postnatal behavioural abnormalities67. This is consistent
with evidence from clinical studies that n-3 PUFA sup-
plementation may be useful in schizophrenia68 and in
individuals at ‘ultra high risk’ for psychosis33.
Although the n-3 PUFA diet in general limited hypo-
methylation in the MIA model, and modiﬁed DHSs and
MECP2 recruitment sites, it did not limit the over-
expression of Abat, Gnas9, Sﬁ1, Cerk, Gnas6 and Oprk1.
This may be in part due to the range of effects of
methylation on gene expression. For example, a large
body of work by Bird et al. suggests that MECP2
recruitment at CpG sites within the genome is methyla-
tion density dependent and it acts as a global transcrip-
tional repressor69,70. On the other hand, work by Zogbi
et al. suggests that MECP2 recruitment can also activate
transcription71. It may also be that other regulatory
regions or interaction with other epimutations not inﬂu-
enced by n-3 PUFA contribute to the regulation of these
genes and potentially explain why their expression
remained unchecked. Nevertheless, inspection of the data
Basil et al. Translational Psychiatry  (2018) 8:125 Page 9 of 12
indicated that dietary n-3 PUFA intervention did tend to
limit MIA-induced changes in Sﬁ1, Cerk, and Gnas6
expression in both sexes; and Gnas9 and Oprk1 in
females. Possibly, n-3 PUFA effects might be speciﬁc to
one sex, but this needs to be examined further in larger
samples to achieve adequate statistical power.
A transcript variant-speciﬁc effect of diet was identiﬁed
in Gnas Complex Locus (please see Supplementary Figure
6). n-3 PUFA had differential effects on two transcript
variants of the Gnas gene including a sex-speciﬁc trend in
expression; therefore its effects on overall expression may
have been masked. Hypomethylation at the promoter
region of transcript variant 6 was restored towards normal
whereas transcript variant 9 was not signiﬁcantly affected.
The Gnas gene has been implicated in autism72 and other
psychiatric disorders73, but there is currently very limited
knowledge about its transcriptional complexity and how
this relates to disease risk. Understanding the impact of
isoform-speciﬁc differential methylation and n-3 PUFA
effect on speciﬁc isoforms of Gnas is challenging but
would be useful to explore further.
Strengths and limitations of the study
This study had several strengths. First, an analytic
approach was adopted which took account of the direc-
tion, extent and signiﬁcance of methylation differences in
MIA-exposed and control animals. It also allowed
examination of the effect of MIA-associated differential
methylation on chromatin state and gene expression.
Second, a comprehensive genome-wide analysis of the
role of epigenetic programming in offspring affected by
environmental risk factors was performed, and the effects
of genotype, age, sex were controlled for. This facilitated
the discovering of DMRs in novel genomic locations as
well as many of which have been previously implicated in
schizophrenia and autism. Finally, it revealed a pre-
ventative effect of n-3 PUFA diet on changes in DNA
methylation.
This study had a number of limitations. First, although
the study had coverage of ~10 000 000 CpG sites in the
mouse genome, it did not provide complete information
about all promoters and CpG islands and limited by the
MspI restriction sites. Moreover, validating DMRs using
an alternative method if not limited by the amount of
sample DNA available would have been beneﬁcial. Sec-
ond, the genome-wide methylation proﬁling was per-
formed in DNA extracted from brain tissue controlling
for weight, but the tissue may still be heterogeneous, and
contain a range of cells of different epigenetic proﬁle.
Third, CpG sites identiﬁed as differentially methylated
were annotated based on their location using the refer-
ence gene boundary, promoter location, deﬁned CpG
location and shores. This may limit identiﬁcation of actual
effects of CpG sites, as enhancers, chromatin modiﬁers
and regulatory factors may act at distant sites. Fourth,
chromatin state information is generated from MNase
sequencing data which captures readily available open
chromatin. This may generate nonspeciﬁc DNA frag-
ments spanning a longer region of the genome. Similarly,
MECP2 is an abundant neuronal protein and its high
afﬁnity for DNA may produce nonspeciﬁc ChIP enrich-
ment. Measures were taken to reduce noise by normal-
ising tag counts and applying a cutoff.
Finally, we did not examine the behavioural con-
sequences of this intervention in the present study. This
was based on increasing evidence that the post-natal
environment also alters neuronal metabolism and struc-
ture74,75 and causes epigenetic changes66, which might
have confounded interpretation. However, we have pre-
viously shown that this same n-3 PUFA intervention
prevented the metabolite changes in the brains of young
adult animals exposed to MIA in-utero; as well as the
emergence of postnatal behavioural abnormalities67.
Conclusions
In conclusion, this is the ﬁrst direct examination of the
impact of prenatal MIA on genome-wide DNA methyla-
tion in mouse hypothalamus. It also examined the effect
of n-3 PUFA intervention on the observed methylation
differences. This study shows that: (1) there was a dif-
ference in global DNA methylation between MIA-affected
and saline control groups; (2) there were numerous DNA
methylation differences genome-wide in the MIA-
exposed adult brain; (3) many of these DMRs detected
were in the promoter or key regulatory regions of novel
genes and those which were implicated as risk genes in
schizophrenia or autism; (4) chromatin state and expres-
sion of genes downstream to the MIA-associated DMRs
was also affected; (5) a number of DMRs detected were
rescued by n-3 PUFA dietary intervention.
We emphasise however, that this work has examined
only one mechanism in which the environment con-
tributes to neurodevelopmental disorders, and only one
approach to modifying its detrimental impact. Our
experiments were conducted under highly controlled
conditions and translating our results from the rodent to
the much more complex human context may not be
straight-forward. They do however suggest that a fuller
understanding how epigenetic mechanisms inﬂuence
brain development may yield practical prevention and/or
treatment targets for neurodevelopmental disorders; and
the possibility of harnessing relatively ‘safe’ low-cost
dietary interventions is worth further study.
Data availability
RRBS data is available in GEO (GSE102942).
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